Published in Biochim Biophys Acta on January 06, 2014
Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol (2014) 2.74
Pericellular proteolysis in cancer. Genes Dev (2014) 0.92
Hyaluronan and RHAMM in wound repair and the "cancerization" of stromal tissues. Biomed Res Int (2014) 0.89
Stroma as an Active Player in the Development of the Tumor Microenvironment. Cancer Microenviron (2014) 0.89
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. Biochim Biophys Acta (2015) 0.84
Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes. PLoS One (2015) 0.80
Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications. Front Oncol (2015) 0.79
The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction. Oncotarget (2016) 0.78
Regulated Hyaluronan Synthesis by Vascular Cells. Int J Cell Biol (2015) 0.78
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX. Oncotarget (2015) 0.78
Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model. Cancer Med (2016) 0.76
Structural basis of collagen recognition by human osteoclast-associated receptor and design of osteoclastogenesis inhibitors. Proc Natl Acad Sci U S A (2016) 0.76
Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor Cells. Front Pharmacol (2016) 0.75
Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature. Clin Cosmet Investig Dermatol (2016) 0.75
Role of tumor microenvironment in tumorigenesis. J Cancer (2017) 0.75
Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model. BMC Cancer (2017) 0.75